News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
August 4, 2021
2021

EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative Medicines

Read article
News
August 3, 2021
2021

Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-beta; Superfamily Member for the Treatment of Cancer

Read article
Event
July 23, 2021
2021

Antibody Discovery, Selection and Screening Digital Week 2021

Read article
Event
July 22, 2021
2021

West Coast Antibody Therapeutics Xchange

Read article
News
July 22, 2021
2021

AbCellera to Report Second Quarter 2021 Financial Results on August 12, 2021

Read article
News
July 13, 2021
2021

AbCellera Appoints Neil Berkley as Chief Business Officer

Read article
News
June 22, 2021
2021

AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada

Read article
News
June 10, 2021
2021

AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares

Read article
Event
June 8, 2021
2021

MaRS Impact Health 2021

Read article
News
May 13, 2021
2021

AbCellera Reports Q1 2021 Business Results

Read article